Teladoc Health developed a methodology to quantify the return on investment (ROI) of its chronic care multi-condition programs covering diabetes management and hypertension management. Teladoc engaged Milliman to conduct a review of this methodology to determine its appropriateness for achieving its goal. This report:

• Provides an overview of Teladoc’s chronic care programs
• Describes Teladoc’s approach to quantifying the ROI for these programs
• Summarizes our opinion of the reasonability of Teladoc’s standard methodology
• Discusses potential limitations of the methodology used by Teladoc
• Outlines important caveats and limitations of Milliman’s review of Teladoc’s methodology

This report was commissioned by Teladoc Health.